Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.
Please consider a small donation if you think this website provides you with relevant information
| Date | Title | Source |
|---|---|---|
| 2024-03-19 6:25:8 am | ADC Therapeutics: Real Opportunity With Real Risk In 2024 (Rating Upgrade) | SeekingAlpha |
| 2024-03-16 5:32:21 am | US$10.00 - That's What Analysts Think ADC Therapeutics SA (NYSE:ADCT) Is Worth After These Results | Simply Wall St. |
| 2024-03-15 9:30:27 am | ADC Therapeutics SA (NYSE:ADCT) Q4 2023 Earnings Call Transcript | Insider Monkey |
| 2024-03-14 2:16:7 am | Q4 2023 ADC Therapeutics SA Earnings Call | Thomson Reuters StreetEvents |
| 2024-03-13 5:51:7 am | ADC Therapeutics SA (ADCT) Reports Mixed 2023 Financial Results Amid Strategic Reset | GuruFocus.com |
| 2024-03-13 5:20:2 am | ADC Therapeutics SA (ADCT) Reports Q4 Loss, Tops Revenue Estimates | Zacks |
| 2024-03-13 4:0:0 am | ADC Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates | GlobeNewswire |
| 2024-03-11 9:34:0 am | Adobe (ADBE) to Report Q1 Earnings: What's in the Offing? | Zacks |
| 2024-03-06 2:20:2 pm | Zymeworks Inc. (ZYME) Reports Q4 Loss, Misses Revenue Estimates | Zacks |
Please consider a small donation if you think this website provides you with relevant information